Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases successfully treated with CIP,% cases successfully treated with TET,% cases successfully treated with CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"17,766 (6,438, 28,482)","66.8% (52.3%, 92.3%)","0.0% (0.0%, 0.0%)","0.0% (0.0%, 0.0%)","66.8% (52.3%, 92.3%)","16.7 (13.1, 23.1)","0.0 (0.0, 0.0)","0.0 (0.0, 0.0)","16.7 (13.1, 23.1)",,,,,
"(p=0.750, q=0.975, c=0.500)","13,700 (6,066, 24,619)","77.1% (59.8%, 98.1%)","18.5% (11.7%, 24.3%)","2.9% (1.6%, 4.9%)","55.7% (42.5%, 72.3%)","19.3 (14.9, 24.5)","4.6 (2.9, 6.1)","0.7 (0.4, 1.2)","13.9 (10.6, 18.1)","-22.0% (-46.9%, -1.4%)","16.0% (3.1%, 32.4%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-16.2% (-26.9%, -4.3%)"
"(p=0.750, q=0.975, c=0.750)","13,730 (6,103, 24,831)","77.5% (59.6%, 98.9%)","27.1% (17.1%, 36.9%)","4.2% (2.3%, 7.3%)","46.2% (36.0%, 62.9%)","19.4 (14.9, 24.7)","6.8 (4.3, 9.2)","1.0 (0.6, 1.8)","11.5 (9.0, 15.7)","-21.8% (-44.4%, -2.5%)","16.5% (4.5%, 32.9%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-30.6% (-42.5%, -17.3%)"
"(p=0.750, q=0.975, c=1.000)","13,721 (6,294, 23,685)","78.0% (59.8%, 98.6%)","36.0% (22.5%, 49.3%)","5.4% (3.0%, 9.4%)","36.7% (25.4%, 53.8%)","19.5 (14.9, 24.6)","9.0 (5.6, 12.3)","1.4 (0.7, 2.4)","9.2 (6.4, 13.5)","-21.8% (-42.8%, -1.0%)","17.4% (4.7%, 32.8%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-44.9% (-60.3%, -27.5%)"
